{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:13:05Z","timestamp":1780402385608,"version":"3.54.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.cardfail.2016.03.017","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T05:37:19Z","timestamp":1461994639000},"page":"829-839","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacologic and Endovascular Reversal of Left Ventricular Remodeling"],"prefix":"10.1016","volume":"22","author":[{"given":"Abhishek","family":"Jaiswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan J.","family":"Carry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry H.","family":"le Jemtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2016.03.017_bib0010","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1161\/01.CIR.91.9.2314","article-title":"Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist","volume":"91","author":"Kass","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0020","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","article-title":"Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment","volume":"57","author":"Merlo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0025","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejheart.2004.11.003","article-title":"Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure","volume":"7","author":"Cioffi","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1388-9842(03)00105-3","volume":"5","author":"Waagstein","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.amjcard.2010.11.033","article-title":"Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and beta blockers in patients with idiopathic dilated cardiomyopathy","volume":"107","author":"Hoshikawa","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0040","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2007.03.062","article-title":"Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure","volume":"50","author":"Chan","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCHEARTFAILURE.114.001357","article-title":"Reversed reverse remodeling: can biomonitoring solve the clinical conundrum of the 3Rs?","volume":"7","author":"Januzzi","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0050","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCHEARTFAILURE.114.001626","article-title":"Left ventricular reverse remodeling with biventricular versus right ventricular pacing in patients with atrioventricular block and heart failure in the BLOCK HF trial","volume":"8","author":"St John Sutton","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCGENETICS.114.000767","article-title":"Therapeutic molecular phenotype of beta-blocker\u2013associated reverse-remodeling in nonischemic dilated cardiomyopathy","volume":"8","author":"Kao","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejheart.2006.09.008","article-title":"Reversal of ventricular remodeling: important to establish and difficult to define","volume":"9","author":"Hauptman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0065","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.jacc.2012.06.062","article-title":"Myocardial recovery and the failing heart: myth, magic, or molecular target?","volume":"60","author":"Mann","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCHEARTFAILURE.109.906909","article-title":"Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction","volume":"3","author":"Udelson","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0075","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0735-1097(94)00543-Y","article-title":"Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade","volume":"25","author":"Hall","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cardfail.2011.11.004","article-title":"New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients\u2014a matter of time for contractility","volume":"18","author":"Bozkurt","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","article-title":"Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN echo substudy","volume":"109","author":"Doughty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure","volume":"86","author":"Konstam","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0095","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)02063-6","article-title":"Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study","volume":"40","author":"Wong","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(02)01965-4","article-title":"Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure","volume":"40","author":"Cicoira","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.CIR.89.1.68","article-title":"Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril","volume":"89","author":"St John Sutton","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0110","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCIMAGING.112.000098","article-title":"Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling","volume":"6","author":"Foster","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ejhf.24","article-title":"Restrictive mitral annuloplasty with or without surgical ventricular reconstruction in ischaemic cardiomyopathy: impacts on neurohormonal activation, reverse left ventricular remodelling and survival","volume":"16","author":"Kainuma","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0120","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/01.CIR.0000065226.24159.E9","article-title":"Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure","volume":"107","author":"St John Sutton","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCOUTCOMES.113.000821","article-title":"Left ventricular reverse remodeling, device-related adverse events, and long-term outcome after cardiac resynchronization therapy in the elderly","volume":"7","author":"Hoke","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijcard.2010.10.125","article-title":"Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL","volume":"146","author":"Ceconi","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0135","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","article-title":"Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy","volume":"32","author":"Tardif","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2011.08.067","article-title":"Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study","volume":"59","author":"Whitlow","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"Kramer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mhj.2003.105","article-title":"Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance","volume":"145","author":"Metra","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0155","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0735-1097(94)90114-7","article-title":"Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study","volume":"24","author":"Eichhorn","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1054\/S1071-9164(03)00133-7","article-title":"A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS","volume":"9","author":"Domanski","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0165","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0735-1097(00)01006-8","article-title":"Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure","volume":"36","author":"Groenning","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0170","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1172\/JCI117277","article-title":"Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation","volume":"93","author":"Tsutsui","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.82.2.473","article-title":"Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol","volume":"82","author":"Eichhorn","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0733-8651(18)30131-0","article-title":"Do beta-blockers have a role in patients with congestive heart failure?","volume":"12","author":"Eichhorn","year":"1994","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0185","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.CIR.90.4.2153","article-title":"Beta-blocker treatment for chronic heart failure. The frog prince","volume":"90","author":"Eichhorn","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0190","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0735-1097(94)90773-0","article-title":"Beta-blockers in heart failure: promising or proved?","volume":"23","author":"Doughty","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl F","key":"10.1016\/j.cardfail.2016.03.017_bib0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/eurheartj\/16.suppl_F.20","article-title":"Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure","volume":"16","author":"Bristow","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0200","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/01.CIR.94.9.2285","article-title":"Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure","volume":"94","author":"Eichhorn","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0205","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.80.3.551","article-title":"Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol","volume":"80","author":"Waagstein","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0210","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0735-1097(97)00012-0","article-title":"Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease","volume":"29","author":"Doughty","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0215","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1388-9842(02)00114-9","article-title":"Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure","volume":"4","author":"Palazzuoli","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0220","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.98.12.1184","article-title":"Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials","volume":"98","author":"Lechat","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0225","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0230","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(99)00059-4","article-title":"Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure","volume":"83","author":"Lowes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0235","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.amjcard.2005.01.030","article-title":"Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy","volume":"95","author":"Green","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0240","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCHEARTFAILURE.113.000813","article-title":"Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after beta-blocker therapy","volume":"7","author":"de Groote","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0245","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","article-title":"Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial","volume":"103","author":"Lechat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0250","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.96.7.2197","article-title":"Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS)","volume":"96","author":"Lechat","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0255","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0260","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0265","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00002018-200831020-00001","article-title":"If inhibition with ivabradine: electrophysiological effects and safety","volume":"31","author":"Savelieva","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0280","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.RES.57.1.84","article-title":"Influence of chronic captopril therapy on the infarcted left ventricle of the rat","volume":"57","author":"Pfeffer","year":"1985","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0285","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.RES.62.4.641","article-title":"Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction","volume":"62","author":"Michel","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0290","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1161\/01.CIR.96.10.3294","article-title":"Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial","volume":"96","author":"St John Sutton","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"6 Suppl","key":"10.1016\/j.cardfail.2016.03.017_bib0300","first-page":"VI40","article-title":"Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II","volume":"87","author":"Francis","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0305","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0315","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0320","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0325","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.HYP.0000146483.78994.56","article-title":"Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition","volume":"44","author":"Cruden","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0330","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0306-5251.2001.1420.x","article-title":"Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP)","volume":"52","author":"Wilkinson","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0335","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0340","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"issue":"11 Pt 2","key":"10.1016\/j.cardfail.2016.03.017_bib0345","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1540-8159.2000.tb07006.x","article-title":"Biventricular pacing in severe heart failure patients reverses electromechanical dyssynchronization from apex to base","volume":"23","author":"Toussaint","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0350","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/eurheartj\/eht160","article-title":"Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study","volume":"34","author":"Linde","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0355","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.hrthm.2014.11.014","article-title":"The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study","volume":"12","author":"Gold","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0360","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.CIR.0000047068.02226.95","article-title":"Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism","volume":"107","author":"Ukkonen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0370","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/hc0402.102623","article-title":"Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure","volume":"105","author":"Yu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0375","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9149(02)03301-5","article-title":"Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure","volume":"91","author":"Trichon","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0380","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.jacc.2014.01.039","article-title":"Percutaneous approaches to valve repair for mitral regurgitation","volume":"63","author":"Feldman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0385","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacc.2010.11.043","article-title":"The acute hemodynamic effects of Mitraclip therapy","volume":"57","author":"Siegel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0390","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.112.001039","article-title":"Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after Mitraclip therapy","volume":"128","author":"Grayburn","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0395","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0400","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.echo.2012.10.010","article-title":"A novel mechanism by which Mitraclip implantation may favorably alter the natural history of left ventricular remodeling in patients with mitral regurgitation: proposed role of the ventricular-valvular loop","volume":"26","author":"Silbiger","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0405","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2013.04.030","article-title":"4-Year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation","volume":"62","author":"Mauri","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0410","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2013.02.094","article-title":"Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the Mitraclip therapy in Europe","volume":"62","author":"Maisano","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0415","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.amjcard.2014.02.028","article-title":"Frequency and predictors of normalization of left ventricular ejection fraction in recent-onset nonischemic cardiomyopathy","volume":"113","author":"Zou","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0420","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1253\/circj.CJ-12-0507","article-title":"Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy","volume":"77","author":"Choi","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0425","doi-asserted-by":"crossref","first-page":"e001504","DOI":"10.1161\/JAHA.114.001504","article-title":"Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long-term follow-up: does real healing exist?","volume":"4","author":"Merlo","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0430","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2012.02.054","article-title":"Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction","volume":"110","author":"Bhat","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0435","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0002-9149(03)00532-0","article-title":"Prevalence, predictors and prognostic implications of improvement in left ventricular systolic function and clinical status in patients >70 years of age with recently diagnosed systolic heart failure","volume":"92","author":"Cioffi","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0440","first-page":"A14985","article-title":"The impact of rapid use of beta-blockers on ventricular remodeling and mortality in end-stage heart failure","volume":"124","author":"Melo","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0445","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCOUTCOMES.111.000045","article-title":"Natural history of left ventricular ejection fraction in patients with heart failure","volume":"6","author":"Clarke","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0450","first-page":"569","article-title":"Systolic heart failure: knowledge gaps, misconceptions, and future directions","volume":"14","author":"Samson","year":"2014","journal-title":"Ochsner J"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0455","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","article-title":"Molecular pathways underlying cardiac remodeling during pathophysiological stimulation","volume":"122","author":"Kehat","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0460","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","article-title":"PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts","volume":"101","author":"Marx","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0465","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1161\/hc4701.099578","article-title":"Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure","volume":"104","author":"Reiken","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0470","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000068316.53218.49","article-title":"Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure","volume":"107","author":"Reiken","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0475","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMoa012630","article-title":"Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents","volume":"346","author":"Lowes","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0480","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/hrt.2004.035618","article-title":"Angiotensin converting enzyme inhibitor prevents left ventricular remodeling after myocardial infarction in angiotensin II type 1 receptor knockout mice","volume":"91","author":"Yoshiyama","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0485","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0490","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardfail.2007.01.005","article-title":"Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy","volume":"13","author":"Iyengar","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0495","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/CIRCULATIONAHA.107.706291","article-title":"Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization","volume":"117","author":"Chakir","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0500","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacc.2007.07.087","article-title":"Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy: responders versus nonresponders","volume":"51","author":"Vanderheyden","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0505","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/CIRCULATIONAHA.108.794834","article-title":"Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy","volume":"119","author":"Aiba","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0510","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCULATIONAHA.108.774752","article-title":"Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy","volume":"119","author":"Chakir","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0515","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCEP.111.962746","article-title":"Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanisms","volume":"5","author":"Cho","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0520","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCRESAHA.111.257428","article-title":"Subcellular structures and function of myocytes impaired during heart failure are restored by cardiac resynchronization therapy","volume":"110","author":"Sachse","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0525","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCHEARTFAILURE.115.002352","article-title":"Cardiac resynchronization therapy reduces subcellular heterogeneity of ryanodine receptors, T-tubules, and Ca2+ sparks produced by dyssynchronous heart failure","volume":"8","author":"Li","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0530","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ejheart.2007.07.007","article-title":"Reverse ventricular remodeling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels","volume":"9","author":"Hessel","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0535","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinbiochem.2012.11.002","article-title":"Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects","volume":"46","author":"Stanciu","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cardfail.2016.03.017_bib0540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1253\/circj.70.321","article-title":"Carvedilol inhibits mitochondrial oxygen consumption and superoxide production during calcium overload in isolated heart mitochondria","volume":"70","author":"Kametani","year":"2006","journal-title":"Circ J"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916416300100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916416300100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T05:22:13Z","timestamp":1567833733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916416300100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":107,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1071916416300100"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2016.03.017","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}